MARKET

CNCR

CNCR

Loncar Cancer Immunotherapy ETF
NASDAQ
14.48
+0.27
+1.90%
Closed 16:00 04/23 EDT
OPEN
14.44
PREV CLOSE
14.21
HIGH
14.65
LOW
14.44
VOLUME
2.47K
TURNOVER
0
52 WEEK HIGH
17.96
52 WEEK LOW
9.22
TOTAL ASSET
17.56M
YTD YIELD
8.62%
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at CNCR last week (0415-0419)?
Weekly Report · 1d ago
Weekly Report: what happened at CNCR last week (0408-0412)?
Weekly Report · 04/15 10:43
Weekly Report: what happened at CNCR last week (0401-0405)?
Weekly Report · 04/08 10:47
Weekly Report: what happened at CNCR last week (0325-0329)?
Weekly Report · 04/01 10:45
The Zacks Analyst Blog Highlights CRPT, WEED, SMH, CNCR and KBWP
NASDAQ · 03/28 12:39
5 Market-Beating Sector ETFs of Q1
NASDAQ · 03/27 15:10
Weekly Report: what happened at CNCR last week (0318-0322)?
Weekly Report · 03/25 10:47
Taking Stock: Q2 2024 Equity Market Outlook
Seeking Alpha · 03/22 15:15
More
Profile
Fund Name
Loncar Cancer Immunotherapy ETF
Inception Date
2015-10-13
Benchmark
Loncar Cancer Immunotherapy TR USD
Advisor Company
Exchange Traded Concepts LLC
Custodian
US Bank NA
Manager
Rafael Zayas, Austin Wen, Andrew Serowik, Gabriel Tan, Todd Alberico, Brian Cooper